Nextcure, INC DEF 14A proxy statements

NextCure, Inc. has filed its 2026 proxy statement to solicit stockholder votes for director elections, auditor ratification, executive compensation, and an equity plan amendment.

NextCure, Inc. has engaged Campaign Management LLC to solicit proxies for its upcoming 2025 Annual Meeting of Stockholders.

NextCure, Inc. has engaged Campaign Management LLC to solicit proxies for its upcoming 2025 Annual Meeting of Stockholders.

NextCure, Inc. is holding its 2025 Annual Meeting on June 20, 2025, and is providing stockholders with information on how to vote on key proposals.

NextCure is asking stockholders to approve a reverse stock split to maintain its Nasdaq listing and is holding advisory votes on executive compensation at its 2025 annual meeting.

NextCure, Inc. will hold its annual stockholder meeting on June 20, 2024, featuring proposals including the election of directors, ratification of the company's accounting firm, and approval of an amendment to the company's certificate of incorporation.

NextCure's upcoming annual meeting on June 20, 2024, will address director elections, auditor ratification, and a key amendment to exculpate company officers from certain liabilities.